Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
JD HEALTH
06618
5
BIDU-SW
09888
| (Q3)Sep 30, 2025 | (Q2)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | 86.15%-95.7K | 50.29%-547.33K | 64.21%-312.52K | 10.98%-3.39M | 27.32%-720.81K | 28.76%-691.15K | -16.47%-1.1M | 2.60%-873.26K | 8.05%-3.8M | 5.10%-991.77K |
| Net income from continuing operations | 39.89%-752.08K | 9.22%-1.29M | 19.31%-959.78K | -0.98%-4.92M | 14.35%-1.06M | -6.54%-1.25M | -27.28%-1.42M | 11.59%-1.19M | 0.02%-4.87M | -12.02%-1.24M |
| Operating gains losses | ---11.29K | --0 | 78.12%-1.09K | ---7.58K | ---2.58K | --0 | --0 | ---5K | ---- | ---- |
| Depreciation and amortization | -0.50%15.44K | -3.02%15.27K | -6.65%15.1K | -5.69%62.87K | -7.34%15.44K | -6.31%15.51K | -5.44%15.74K | -3.71%16.18K | 30.97%66.67K | -6.23%16.66K |
| Remuneration paid in stock | -94.01%30.89K | 328.64%354.6K | 165.10%141.84K | 38.75%684.46K | -67.69%32.51K | 376.02%515.72K | -26.94%82.73K | -68.73%53.5K | -38.19%493.3K | -50.64%100.61K |
| Deferred tax | ---- | ---- | ---- | ---83.48K | ---- | ---- | ---- | ---- | --0 | ---- |
| Other non cashItems | 104.22%129.66K | 270.30%121.75K | 693.01%100.33K | 220.31%178.46K | 423.64%69.44K | 360.03%63.49K | 130.46%32.88K | -12.05%12.65K | -74.46%55.71K | -75.46%13.26K |
| Change In working capital | 1,512.74%491.69K | 33.44%249.69K | 63.73%391.08K | 54.44%698.64K | 167.80%307.47K | -153.25%-34.8K | 626.72%187.12K | -3.08%238.85K | 236.64%452.36K | 153.07%114.82K |
| -Change in receivables | 18.48%-66.01K | 155.92%198.54K | -107.65%-5.83K | -61.30%34.32K | -110.90%-38.46K | -106.35%-80.97K | 965.52%77.58K | -50.89%76.18K | 150.19%88.68K | 74.98%-18.24K |
| -Change in prepaid assets | 108.23%14.57K | 131.37%47.23K | 201.23%54.37K | -326.93%-105.63K | 28.58%32.92K | -1,165.00%-177.01K | 483.88%20.42K | -55.16%18.05K | 168.84%46.55K | 131.75%25.6K |
| -Change in payables and accrued expense | 77.27%530.08K | -96.49%3.92K | 404.80%342.54K | 177.39%791.49K | 112.03%313.01K | 152.15%299.03K | 2,091.91%111.59K | 174.55%67.86K | 428.87%285.33K | 335.04%147.63K |
| -Change in other working capital | ---- | ---- | ---- | -167.73%-21.54K | --0 | ---75.85K | -149.23%-22.46K | 191.32%76.77K | --31.81K | ---40.18K |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | 86.15%-95.7K | 50.29%-547.33K | 64.21%-312.52K | 10.98%-3.39M | 27.32%-720.81K | 28.76%-691.15K | -16.47%-1.1M | 2.60%-873.26K | 8.05%-3.8M | 5.10%-991.77K |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | ||||||||||
| Cash from discontinued investing activities | ||||||||||
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | -115.02%-73.37K | -60.11%413.34K | 2,001.38%604.11K | 2,249.60%2.2M | 2,505.90%707.26K | 1,930.96%488.5K | 3,326.72%1.04M | -124.32%-31.77K | -216.78%-102.36K | -331.02%-29.4K |
| Net issuance payments of debt | -112.83%-34.73K | -93.64%69.72K | 1,044.88%655.72K | 1,582.50%1.52M | 850.43%220.6K | 1,114.25%270.6K | 3,511.61%1.1M | -389.95%-69.4K | -101.88%-102.36K | -99.23%-29.4K |
| Net common stock issuance | ---- | ---- | ---- | --554.93K | ---- | ---- | ---- | ---- | --0 | ---- |
| Cash dividends paid | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | ---- |
| Proceeds from stock option exercised by employees | -92.22%20.6K | --323.63K | 19.43%44.94K | --302.38K | --0 | --264.75K | --0 | --37.63K | --0 | --0 |
| Interest paid (cash flow from financing activities) | ---9.58K | --0 | ---22.69K | ---14.92K | ---14.92K | --0 | --0 | --0 | --0 | ---- |
| Net other financing activities | -6.00%-49.66K | --20K | ---73.86K | ---159.57K | ---53.34K | ---46.85K | ---- | ---- | ---- | ---- |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | -115.02%-73.37K | -60.11%413.34K | 2,001.38%604.11K | 2,249.60%2.2M | 2,505.90%707.26K | 1,930.96%488.5K | 3,326.72%1.04M | -124.32%-31.77K | -216.78%-102.36K | -331.02%-29.4K |
| Net cash flow | ||||||||||
| Beginning cash position | -18.58%248.82K | -5.96%352.67K | -95.32%60.55K | -75.04%1.29M | -95.19%110.69K | -90.77%305.62K | -91.23%375.01K | -75.04%1.29M | -44.05%5.19M | -62.91%2.3M |
| Current changes in cash | 16.57%-169.07K | -106.94%-133.99K | 132.22%291.59K | 69.64%-1.19M | 98.67%-13.55K | 79.67%-202.65K | 93.38%-64.75K | 0.63%-905.03K | 3.53%-3.91M | 1.08%-1.02M |
| Effect of exchange rate changes | -247.88%-11.43K | 748.57%30.14K | 103.74%535 | -422.57%-47.82K | -402.19%-36.6K | 178.97%7.73K | -138.55%-4.65K | -3,301.12%-14.31K | 143.48%14.83K | 47.45%12.11K |
| End cash Position | -38.28%68.32K | -18.58%248.82K | -5.96%352.67K | -95.32%60.55K | -95.32%60.55K | -95.19%110.69K | -90.77%305.62K | -91.23%375.01K | -75.04%1.29M | -75.04%1.29M |
| Free cash from | 86.15%-95.7K | 50.29%-547.33K | 64.21%-312.52K | 10.98%-3.39M | 27.32%-720.81K | 28.76%-691.15K | -16.47%-1.1M | 2.60%-873.26K | 8.05%-3.8M | 5.10%-991.77K |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.